Leukaemia

14,000,000 Leading Edge Experts on the ideXlab platform

Scan Science and Technology

Contact Leading Edge Experts & Companies

Scan Science and Technology

Contact Leading Edge Experts & Companies

The Experts below are selected from a list of 267 Experts worldwide ranked by ideXlab platform

Kiyoshi Takatsuki - One of the best experts on this subject based on the ideXlab platform.

  • myelomonoblastic Leukaemia cells carrying the pebp2β myh11 fusion gene are cd34 c kit immature cells
    British Journal of Haematology, 1997
    Co-Authors: Motomi Osato, Norio Asou, Toshiya Okubo, Shintaro Nishimura, Hitoshi Suzushima, Hiroshi Yamasaki, Rumiko Matsuoka, Fumio Kawano, Kiyoshi Takatsuki
    Abstract:

    To clarify the aspects affected by the PEBP2β/MYH11 fusion gene involved in the inv(16), we analysed immunophenotypes in myelomonoblastic Leukaemias. We found high expressions of CD34 and c-KIT antigens in myelomonoblastic cells from all patients carrying this fusion gene, including two with M4 and one CML blastic phase, in contrast to those with M4 without the fusion gene. These findings indicate that immunophenotyping is useful for detecting a Leukaemia with the fusion gene in myelomonoblastic Leukaemias and that the PEBP2β/MYH11 gene is involved in immature cells expressing CD34 and c-KIT antigens.

Motomi Osato - One of the best experts on this subject based on the ideXlab platform.

  • myelomonoblastic Leukaemia cells carrying the pebp2β myh11 fusion gene are cd34 c kit immature cells
    British Journal of Haematology, 1997
    Co-Authors: Motomi Osato, Norio Asou, Toshiya Okubo, Shintaro Nishimura, Hitoshi Suzushima, Hiroshi Yamasaki, Rumiko Matsuoka, Fumio Kawano, Kiyoshi Takatsuki
    Abstract:

    To clarify the aspects affected by the PEBP2β/MYH11 fusion gene involved in the inv(16), we analysed immunophenotypes in myelomonoblastic Leukaemias. We found high expressions of CD34 and c-KIT antigens in myelomonoblastic cells from all patients carrying this fusion gene, including two with M4 and one CML blastic phase, in contrast to those with M4 without the fusion gene. These findings indicate that immunophenotyping is useful for detecting a Leukaemia with the fusion gene in myelomonoblastic Leukaemias and that the PEBP2β/MYH11 gene is involved in immature cells expressing CD34 and c-KIT antigens.

  • Myelomonoblastic Leukaemia cells carrying the PEBP2β/MYH11 fusion gene are CD34+, c-KIT+ immature cells
    British Journal of Haematology, 1997
    Co-Authors: Motomi Osato, Norio Asou, Toshiya Okubo, Shintaro Nishimura, Hitoshi Suzushima, Hiroshi Yamasaki, Fumio Kawano, Rumiko Matsuoka
    Abstract:

    To clarify the aspects affected by the PEBP2β/MYH11 fusion gene involved in the inv(16), we analysed immunophenotypes in myelomonoblastic Leukaemias. We found high expressions of CD34 and c-KIT antigens in myelomonoblastic cells from all patients carrying this fusion gene, including two with M4 and one CML blastic phase, in contrast to those with M4 without the fusion gene. These findings indicate that immunophenotyping is useful for detecting a Leukaemia with the fusion gene in myelomonoblastic Leukaemias and that the PEBP2β/MYH11 gene is involved in immature cells expressing CD34 and c-KIT antigens.

Rumiko Matsuoka - One of the best experts on this subject based on the ideXlab platform.

  • myelomonoblastic Leukaemia cells carrying the pebp2β myh11 fusion gene are cd34 c kit immature cells
    British Journal of Haematology, 1997
    Co-Authors: Motomi Osato, Norio Asou, Toshiya Okubo, Shintaro Nishimura, Hitoshi Suzushima, Hiroshi Yamasaki, Rumiko Matsuoka, Fumio Kawano, Kiyoshi Takatsuki
    Abstract:

    To clarify the aspects affected by the PEBP2β/MYH11 fusion gene involved in the inv(16), we analysed immunophenotypes in myelomonoblastic Leukaemias. We found high expressions of CD34 and c-KIT antigens in myelomonoblastic cells from all patients carrying this fusion gene, including two with M4 and one CML blastic phase, in contrast to those with M4 without the fusion gene. These findings indicate that immunophenotyping is useful for detecting a Leukaemia with the fusion gene in myelomonoblastic Leukaemias and that the PEBP2β/MYH11 gene is involved in immature cells expressing CD34 and c-KIT antigens.

  • Myelomonoblastic Leukaemia cells carrying the PEBP2β/MYH11 fusion gene are CD34+, c-KIT+ immature cells
    British Journal of Haematology, 1997
    Co-Authors: Motomi Osato, Norio Asou, Toshiya Okubo, Shintaro Nishimura, Hitoshi Suzushima, Hiroshi Yamasaki, Fumio Kawano, Rumiko Matsuoka
    Abstract:

    To clarify the aspects affected by the PEBP2β/MYH11 fusion gene involved in the inv(16), we analysed immunophenotypes in myelomonoblastic Leukaemias. We found high expressions of CD34 and c-KIT antigens in myelomonoblastic cells from all patients carrying this fusion gene, including two with M4 and one CML blastic phase, in contrast to those with M4 without the fusion gene. These findings indicate that immunophenotyping is useful for detecting a Leukaemia with the fusion gene in myelomonoblastic Leukaemias and that the PEBP2β/MYH11 gene is involved in immature cells expressing CD34 and c-KIT antigens.

Shintaro Nishimura - One of the best experts on this subject based on the ideXlab platform.

  • myelomonoblastic Leukaemia cells carrying the pebp2β myh11 fusion gene are cd34 c kit immature cells
    British Journal of Haematology, 1997
    Co-Authors: Motomi Osato, Norio Asou, Toshiya Okubo, Shintaro Nishimura, Hitoshi Suzushima, Hiroshi Yamasaki, Rumiko Matsuoka, Fumio Kawano, Kiyoshi Takatsuki
    Abstract:

    To clarify the aspects affected by the PEBP2β/MYH11 fusion gene involved in the inv(16), we analysed immunophenotypes in myelomonoblastic Leukaemias. We found high expressions of CD34 and c-KIT antigens in myelomonoblastic cells from all patients carrying this fusion gene, including two with M4 and one CML blastic phase, in contrast to those with M4 without the fusion gene. These findings indicate that immunophenotyping is useful for detecting a Leukaemia with the fusion gene in myelomonoblastic Leukaemias and that the PEBP2β/MYH11 gene is involved in immature cells expressing CD34 and c-KIT antigens.

  • Myelomonoblastic Leukaemia cells carrying the PEBP2β/MYH11 fusion gene are CD34+, c-KIT+ immature cells
    British Journal of Haematology, 1997
    Co-Authors: Motomi Osato, Norio Asou, Toshiya Okubo, Shintaro Nishimura, Hitoshi Suzushima, Hiroshi Yamasaki, Fumio Kawano, Rumiko Matsuoka
    Abstract:

    To clarify the aspects affected by the PEBP2β/MYH11 fusion gene involved in the inv(16), we analysed immunophenotypes in myelomonoblastic Leukaemias. We found high expressions of CD34 and c-KIT antigens in myelomonoblastic cells from all patients carrying this fusion gene, including two with M4 and one CML blastic phase, in contrast to those with M4 without the fusion gene. These findings indicate that immunophenotyping is useful for detecting a Leukaemia with the fusion gene in myelomonoblastic Leukaemias and that the PEBP2β/MYH11 gene is involved in immature cells expressing CD34 and c-KIT antigens.

Hitoshi Suzushima - One of the best experts on this subject based on the ideXlab platform.

  • myelomonoblastic Leukaemia cells carrying the pebp2β myh11 fusion gene are cd34 c kit immature cells
    British Journal of Haematology, 1997
    Co-Authors: Motomi Osato, Norio Asou, Toshiya Okubo, Shintaro Nishimura, Hitoshi Suzushima, Hiroshi Yamasaki, Rumiko Matsuoka, Fumio Kawano, Kiyoshi Takatsuki
    Abstract:

    To clarify the aspects affected by the PEBP2β/MYH11 fusion gene involved in the inv(16), we analysed immunophenotypes in myelomonoblastic Leukaemias. We found high expressions of CD34 and c-KIT antigens in myelomonoblastic cells from all patients carrying this fusion gene, including two with M4 and one CML blastic phase, in contrast to those with M4 without the fusion gene. These findings indicate that immunophenotyping is useful for detecting a Leukaemia with the fusion gene in myelomonoblastic Leukaemias and that the PEBP2β/MYH11 gene is involved in immature cells expressing CD34 and c-KIT antigens.

  • Myelomonoblastic Leukaemia cells carrying the PEBP2β/MYH11 fusion gene are CD34+, c-KIT+ immature cells
    British Journal of Haematology, 1997
    Co-Authors: Motomi Osato, Norio Asou, Toshiya Okubo, Shintaro Nishimura, Hitoshi Suzushima, Hiroshi Yamasaki, Fumio Kawano, Rumiko Matsuoka
    Abstract:

    To clarify the aspects affected by the PEBP2β/MYH11 fusion gene involved in the inv(16), we analysed immunophenotypes in myelomonoblastic Leukaemias. We found high expressions of CD34 and c-KIT antigens in myelomonoblastic cells from all patients carrying this fusion gene, including two with M4 and one CML blastic phase, in contrast to those with M4 without the fusion gene. These findings indicate that immunophenotyping is useful for detecting a Leukaemia with the fusion gene in myelomonoblastic Leukaemias and that the PEBP2β/MYH11 gene is involved in immature cells expressing CD34 and c-KIT antigens.